Price movement over the last 24 hours
AdaptHealth Corp vs First Citizens BancShares Inc — how do they compare? AdaptHealth Corp trades at $10.04 (market cap $1.38B), while First Citizens BancShares Inc trades at $2,045.06 (market cap $23.94B). The key difference: First Citizens BancShares Inc is far larger — about 17.3× AdaptHealth Corp's market cap, and First Citizens BancShares Inc pays a 0.4% dividend while AdaptHealth Corp pays none. Which is the better fit depends on your goals.
| AHCO | FCNCA | |
|---|---|---|
Market Cap | $1.38B | $23.94B |
Sector | Health | Sector/Thematic |
52-Week High | $13.38 | $2.20K |
52-Week Low | $8.68 | $1.64K |
Enterprise Value | $3.33B | — |
Dividend Yield | — | 0.4% |
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.
The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.
First Citizens BancShares (FCNCA) trades at $2,117.35, up 1.65% on the day, with a bullish technical signal from moving averages. The stock shows strong fundamental health with a P/E of 12.21 and net income margin of 24.35%, supported by consecutive earnings beats including Q1 2026 EPS of $44.86 versus $39.56 expected. Recent corporate developments include the planned rebranding of Silicon Valley Bank and expansion of commercial banking capabilities.
The outlook remains positive given earnings momentum and analyst consensus price target of $2,320, though risks include margin pressure and credit exposure from the SVB integration. Upside potential hinges on continued execution amid a competitive banking landscape.
Trailing returns across standard periods
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.
Read more on FCNCA →